Mettlin CJ Murphy GP Rosenthal DS The National Cancer Data Base report on prostate carcinoma after the peak in incidence rates in the U.S. The American College of Surgeons Commission on Cancer and the American Cancer Society Cancer 1998 83 1679-84 
Mettlin CJ Murphy GP McDonald CJ The National Cancer Data Base Report on increased use of brachytherapy for the treatment of patients with prostate carcinoma in the U.S Cancer 1999 86 1877-82 
Shipley WU Thames HD Sandler HM Radiation therapy for clinically localized prostate cancer: a multi-institutional pooled analysis JAMA 1999 281 1598-604 
D&#8217;Amico AV Chen MH Renshaw AA Loffredo B Kantoff PW Risk of prostate cancer recurrence in men treated with radiation alone or in conjunction with combined or less than combined androgen suppression therapy J Clin Oncol 2008 26 2979-83 
Suzuki N Shimbo M Amiya Y Outcome of patients with localized prostate cancer treated by radiotherapy after confirming the absence of lymph node invasion Jpn J Clin Oncol 2010 40 652-7 
Touma NJ Izawa JI Chin JL Current status of local salvage therapies following radiation failure for prostate cancer J Urol 2005 173 373-9 
Zietman AL Bae K Slater JD Randomized trial comparing conventional-dose with high-dose conformal radiation therapy in early-stage adenocarcinoma of the prostate: long-term results from proton radiation oncology group/American College of radiology 95&#8211;09 J Clin Oncol 2010 28 1106-11 
Crook JM Perry GA Robertson S Esche BA Routine biopsies following radiotherapy for prostate cancer: results for 226 patients Urology 1995 45 624-31 
Siddiqui SA Mynderse LA Zincke H Treatment of prostate cancer local recurrence after radical retropubic prostatectomy with 17-gauge interstitial transperineal cryoablation: initial experience Urology 2007 70 80-5 
Chin JL Lim D Abdelhady M Review of primary and salvage cryoablation for prostate cancer Cancer Control 2007 14 231-7 
Finley DS Pouliot F Miller DR Belldegrun AS Primary and salvage cryotherapy for prostate cancer Urol Clin North Am 2010 37 67-82 
Babaian RJ Donnelly B Bahn D AUA Best practice statement on cryosurgery for the treatment of localized prostate cancer J Urol 2008 180 1993-2004 
Nguyen PL D'Amico AV Lee AK Suh WW Patient selection, cancer control, and complications after salvage local therapy for postradiation prostate-specific antigen failure: a systematic review of the literature Cancer 2007 110 1417-28 
Spiess PE Lee AK Leibovici D Presalvage prostate-specific antigen and PSA doubling time as predictors of biochemical failure of salvage cryotherapy in patients with locally recurrent prostate cancer after radiotherapy Cancer 2006 107 275-80 
Vergunst H Langenhuijsen JF Rebuttal from Authors re: J. Stephen Jones. Ten Misconceptions regarding cryotherapy for prostate cancer Eur Urol 2009 55 52-5 
Chin JL Pautler SE Mouraviev V Results of salvage cryoablation of the prostate after radiation: identifying predictors of treatment failure and complications J Urol 2001 165 1937-42 
Taille A Benson MC Bagiella E Cryoablation for clinically localized prostate cancer using an argon-based system: complication rates and biochemical recurrence BJU Int 2000 85 281-6 
Izawa JI Madsen LT Scott SM Salvage cryotherapy for recurrent prostate cancer after radiotherapy: variables affecting patient outcome J Clin Oncol 2002 20 2664-71 
Pisters LL Perrotte P Scott SM Patient selection for salvage cryotherapy for locally recurrent prostate cancer after radiation therapy J Clin Oncol 1999 17 2514-20 
Spiess PE Katz AE Chin JL A pretreatment nomogram predicting biochemical failure after salvage cryotherapy for locally recurrent prostate cancer BJU Int 2009 106 194-8 
Bahn DK Lee F Silverman P Salvage cryosurgery for recurrent prostate cancer after radiation therapy: a seven-year follow-up Clin Prostate Cancer 2003 2 111-4 
Cheetham P Truesdale M Chaudhury S Long-term cancer-specific and overall survival for men followed more than 10 years after primary and salvage cryoablation of the prostate J Endo 2010 24 1123-9 
Huang WC Kuroiwa K Serio AM The anatomical and pathological characteristics of irradiated prostate cancers may influence the oncological efficacy of salvage ablative therapies J Urol 2007 177 1324-9 
Klossner DP Baust JM VanBuskirk RG Gage AA Baust JG Cryoablative response of prostate cancer cells is influenced by androgen receptor expression BJU Int 2008 101 1310-6 
Eisenberg ML Shinohara K Partial salvage cryoablation of the prostate for recurrent prostate cancer after radiotherapy failure Urology 2008 72 1315-8 
Abdelhady M Abusamra A Elmaadawi A Health related quality of life (HRQOL) outcome after salvage cryosurgery of the prostate: comparison with outcome after primary radiotherapy J Urol suppl 2007 177 3 
Robinson JW Donnelly BJ Coupland K Quality of life 2 years after salvage cryosurgery for the treatment of local recurrence of prostate cancer after radiotherapy Urol Oncol 2006 24 472-86 
Perrotte P Litwin M McGuire EJ Quality of life after salvage cryotherapy: the impact of treatment parameters J Urol 1999 162 398-402 
Levy DA Correlation of thermocouple data with voiding function after prostate cryoablation Urology 2010 75 482-7 
Taille A Hayek O Benson MC Salvage cryotherapy for recurrent prostate cancer after radiation treatment: the Columbia experience Urology 2000 55 79-84 
Long JP Fallick ML LaRock DR Rand W Preliminary outcomes following cryosurgical ablation of the prostate in patients with clinically localized prostate carcinoma J Urol 1998 159 477-84 
Anastasiadis AG Sachdev R Salomon L Comparison of health-related quality of life and prostate-associated symptoms after primary and salvage cryotherapy for prostate cancer J Cancer Res Clin Oncol 2003 129 676-82 
Ismail M Ahmed S Kastner C Davies J Salvage cryotherapy for recurrent prostate cancer after radiation failure: a prospective case series of the first 100 patients BJU Int 2007 100 760-4 
Pisters LL Rewcastle JC Donnelly BJ Salvage prostate cryoablation: initial results from the cryo on-line data registry J Urol 2008 180 559-64 
